Airway clearance techniques for bronchiectasis
Efficacy and Safety of Airway Clearance Technique by Oscillation and Lung Expansion in Patients With Bronchiectasis
NA · Shanghai Pulmonary Hospital, Shanghai, China · NCT06393257
This study tests a new airway clearance technique to see if it helps people with bronchiectasis feel better and clear mucus more effectively than the traditional method.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Shanghai Pulmonary Hospital, Shanghai, China (other) |
| Locations | 3 sites (Shanghai, Shanghai Municipality and 2 other locations) |
| Trial ID | NCT06393257 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness and safety of an airway clearance technique called Oscillation and Lung Expansion in patients with bronchiectasis. Participants will be randomly assigned to receive either this new technique or traditional postural drainage. The study aims to compare symptom relief, quality of life, and the amount of mucus expectorated between the two groups. By evaluating these outcomes, the trial seeks to determine the superior method for managing bronchiectasis exacerbations.
Who should consider this trial
Good fit: Ideal candidates for this study are adults experiencing acute exacerbations of bronchiectasis.
Not a fit: Patients with severe complications such as significant haemoptysis or recent lung surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective airway clearance method for patients with bronchiectasis, improving their quality of life.
How similar studies have performed: While similar airway clearance techniques have been explored, this specific approach is novel and has not been extensively tested in bronchiectasis.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with acute exacerbation of bronchiectasis Exclusion Criteria: * Haemoptysis greater than 50ml * state of endangerment * pneumothorax * Lung surgery history within 6 months * Severe heart, brain and nervous system diseases
Where this trial is running
Shanghai, Shanghai Municipality and 2 other locations
- Ruijin Hospital — Shanghai, Shanghai Municipality, China (RECRUITING)
- Shanghai pulmonary hospital — Shanghai, Shanghai Municipality, China (RECRUITING)
- The Shanghai First People's Hospital — Shanghai, Shanghai Municipality, China (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Jin-Fu Xu, PhD — Shanghai Pulmonary Hospital, Shanghai, China
- Study coordinator: Jin-Fu Xu, PhD
- Email: jfxucn@163.com
- Phone: +8613321922898
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Bronchiectasis Adult, bronchiectasis, Airway Clearance Technique